Reproductive BioMedicine Online
Volume 19, Issue 5 , Pages 619-630 , November 2009

Low-dose HCG may improve pregnancy rates and lower OHSS in antagonist cycles: a meta-analysis

The data included in this study were presented as a poster at the 24th Annual Meeting of the European Society of Human Reproduction and Embryology, Barcelona, July, 2008.

  • IP Kosmas

      Affiliations

    • Centre for Reproductive Medicine, Department of Obstetrics and Gynecology, Ioannina University School of Medicine, Ioannina, Greece
    • Corresponding Author InformationCorrespondence:
    • ,
  • K Zikopoulos

      Affiliations

    • Centre for Reproductive Medicine, Department of Obstetrics and Gynecology, Ioannina University School of Medicine, Ioannina, Greece
    • ,
  • I Georgiou

      Affiliations

    • Centre for Reproductive Medicine, Department of Obstetrics and Gynecology, Ioannina University School of Medicine, Ioannina, Greece
    • ,
  • E Paraskevaidis

      Affiliations

    • Centre for Reproductive Medicine, Department of Obstetrics and Gynecology, Ioannina University School of Medicine, Ioannina, Greece
    • ,
  • C Blockeel

      Affiliations

    • Centre for Reproductive Medicine, University Hospital, Vrije Univestiteit Brussels (Free University of Brussels), Belgium
    • ,
  • H Tournaye

      Affiliations

    • Centre for Reproductive Medicine, University Hospital, Vrije Univestiteit Brussels (Free University of Brussels), Belgium
    • ,
  • J Van der Elst

      Affiliations

    • Centre for Reproductive Medicine, University Hospital, Vrije Univestiteit Brussels (Free University of Brussels), Belgium
    • ,
  • P Devroey

      Affiliations

    • Centre for Reproductive Medicine, University Hospital, Vrije Univestiteit Brussels (Free University of Brussels), Belgium

Received 9 April 2008 ,Revised 16 September 2008 ,Accepted 3 June 2009.

References 

  1. Al-Inany HG, Abou-Setta AM, Aboulghar MA, et al. HMG versus rFSH for ovulation induction in developing countries: a cost-effectiveness analysis based on the results of a recent meta-analysis. Reproductive BioMedicine Online. 2006;2:163–169
  2. Baruffi RL, Mauri AL, Petersen CG, et al. Recombinant LH supplementation to recombinant FSH during induced ovarian stimulation in the GnRH-antagonist protocol: a meta-analysis. Reproductive BioMedicine Online. 2007;1:14–25
  3. Berkkanoglu M, Isikoglu M, Aydin D, et al. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders. Fertility and Sterility. 2007;3:665–669
  4. Chun SY, Eisenhauer KM, Minami S, et al. Hormonal regulation of apoptosis in early antral follicles: follicle-stimulating hormone as a major survival factor. Endocrinology. 1996;4:1447–1456
  5. Davies E, Check JH, Brasile JK, et al. A prospective comparison of in-vitro fertilization (IVF) outcome following controlled ovarian hyperstimulation (COH) regimens using follitropin alpha exclusively or with the addition of low-dose human chorionic gonadotropin (hCG). Fertility and Sterility. 2006;85(suppl. 2):16
  6. d’Hauterive SP, Berndt S, Tsampalas M, et al. Dialogue between blastocyst hCG and endometrial LH/hCG receptor: which role in implantation?. Gynecological and Obstetrical Investigation. 2007;3:156–160
  7. Dzik A, Freitas GC, De Pauwn K, et al. Efficacy of low-dose HCG alone following Recombinant FSH for controlled ovarian stimulation. Fertility and Sterility. 2006;3(suppl. 1):S427
  8. Fanchin R, Righini C, Olivennes F, et al. Consequences of premature progesterone elevation on the outcome of in-vitro fertilization: insights into a controversy. Fertility and Sterility. 1997;5:799–805
  9. Fanchin R, Righini C, Olivennes F, et al. Premature progesterone elevation does not alter oocyte quality in in-vitro fertilization. Fertility and Sterility. 1996;6:1178–1183
  10. Fatum M, Gyo Y, Diana P, et al. Is estradiol mandatory for an adequate follicular and embryo development? A mouse model using aromatase inhibitor (anastrozole). Journal of Assisted Reproduction and Genetics. 2006;23:407–412
  11. Filicori M, Cognigni GE, Gamberini E, et al. Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation. Fertility and Sterility. 2005;2:394–401
  12. Filicori M, Fazleabas AT, Huhtaniemi I, et al. Novel concepts of human chorionic gonadotropin: reproductive system interactions and potential in the management of infertility. Fertility and Sterility. 2005;2:275–284
  13. Filicori M, Cognigni GE, Tabarelli C, et al. Stimulation and growth of antral ovarian follicles by selective LH activity administration in women. The Journal of Clinical Endocrinology and Metabolism. 2002;3:1156–1161
  14. Filicori M, Cognigni GE, Taraborrelli S, et al. Low-dose human chorionic gonadotropin therapy can improve sensitivity to exogenous follicle-stimulating hormone in patients with secondary amenorrhea. Fertility and Sterility. 1999;6:1118–1120
  15. Frattarelli JL, Miller KA, Kaplan B, et al. Does leutinizing hormone activity in the form of low-dose HCG or HMG produce better outcomes for GNRH antagonist ART cycles stimulated with rFSH?. Fertility and Sterility. 2007;88(suppl. 1):S132
  16. Garcia-Velasco JA, Coelingh Bennink HJ, Epifanio R, et al. High-dose recombinant LH add-back strategy using high-dose GnRH antagonist is an innovative protocol compared with standard GnRH antagonist. Reproductive BioMedicine Online. 2007;3:280–287
  17. Gomes MK, Vieira CS, Moura MD, et al. Controlled ovarian stimulation with exclusive FSH followed by stimulation with hCG alone, FSH alone or hMG. European Journal of Obstetrics, Gynecology and Reproductive Biology. 2007;1:99–106
  18. Han SW, Lei ZM, Rao CV. Treatment of human endometrial stromal cells with chorionic gonadotropin promotes their morphological and functional differentiation into decidua. Molecular and Cellular Endocrinology. 1999;14:7–16
  19. Han SW, Lei ZM, Rao CV. Up-regulation of cyclooxygenase-2 gene expression by chorionic gonadotropin during the differentiation of human endometrial stromal cells into decidua. Endocrinology. 1996;5:1791–1797
  20. Jasinska A, Strakova Z, Szmidt M, Fazleabas AT. Human chorionic gonadotropin and decidualization in vitro inhibits cytochalasin-d-induced apoptosis in cultured endometrial stromal fibroblasts. Endocrinology. 2006;9:4112–4121
  21. Koichi K, Yukiko N, Shima K, et al. Efficacy of low-dose human chorionic gonadotropin (hCG) in a GnRH antagonist protocol. Journal of Assisted Reproduction and Genetics. 2006;5:223–228
  22. Kolibianakis EM, Collins J, Tarlatzis B, et al. Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic review. Human Reproduction Update. 2006;1:3–12
  23. Kolibianakis EM, Albano C, Camus M, et al. Initiation of gonadotropin-releasing hormone antagonist on day 1 as compared to day 6 of stimulation: effect on hormonal levels and follicular development in in-vitro fertilization cycles. The Journal of Clinical Endocrinology and Metabolism. 2003;12:5632–5637
  24. Kosmas IP, Kolibianakis EM, Devroey P. Association of estradiol levels on the day of hCG administration and pregnancy achievement in IVF: a systematic review. Human Reproduction. 2004;11:2446–2453
  25. Licht P, Russu V, Wildt L. On the role of human chorionic gonadotropin (hCG) in the embryo-endometrial microenvironment: implications for differentiation and implantation. Seminars in Reproductive Medicine. 2001;1:37–47
  26. Lovely LP, Fazleabas AT, Fritz MA, et al. Prevention of endometrial apoptosis: randomized prospective comparison of human chorionic gonadotropin versus progesterone treatment in the luteal phase. The Journal of Clinical Endocrinology and Metabolism. 2005;4:2351–2356
  27. Mendes IR, Kotecki JA, Caldeira G, et al. Will the administration of low-dose hCG for ovulation induction in association with bromocriptine aid in the prevention of OHSS?. Fertility and Sterility. 2005;84(suppl. 1):S313
  28. Mihm M, Baker PJ, Ireland Jl, et al. Molecular evidence that growth of dominant follicles involves a reduction in follicle-stimulating hormone dependence and an increase in luteinizing hormone dependence in cattle. Biology of Reproduction. 2006;6:1051–1059
  29. Morris RS, Francis MM, Do YS, et al. Angiotensin II (AII) modulation of steroidogenesis by luteinized granulosa cells in vitro. Journal of Assisted Reproduction and Genetics. 1994;3:117–122
  30. Nargund G, Hutchinson L, Scaramuzzi R, et al. Low-dose HCG is useful in preventing OHSS in high-risk women without adversely affecting the outcome of IVF cycles. Reproductive BioMedicine Online. 2007;6:682–685
  31. Ruvolo G, Bosco L, Pane A, et al. Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in-vitro fertilization procedures. Fertility and Sterility. 2007;3:542–546
  32. Serafini P, Yadid I, Motta EL, et al. Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in-vitro fertilization: a prospective, randomized trial. Fertility and Sterility. 2006;4:830–838
  33. Van Horne AK, Bates GW, Robinson RD, et al. Recombinant follicle-stimulating hormone (rFSH) supplemented with low-dose human chorionic gonadotropin compared with rFSH alone for ovarian stimulation for in-vitro fertilization. Fertility and Sterility. 2007;4:1010–1013

 Ioannis Kosmas MD, MSc, PhD, completed his specialty degree in 2002 at the University of Ioannina, Medical School, Greece. After that he spent some time at the Center of Minimal Invasive Surgery at Royal Free Hospital, London (2003) and at the Center of Reproductive Medicine at the Dutch-speaking Free University of Brussels (2004–2007) where he obtained his subspecialty in Reproductive Medicine. His special interest includes meta-analysis and decision sciences, pharmaco-economics and molecular imaging in embryo implantation. Dr Ioannis Kosmas

PII: S1472-6483(09)00071-6

doi: 10.1016/j.rbmo.2009.09.007

Reproductive BioMedicine Online
Volume 19, Issue 5 , Pages 619-630 , November 2009

Article Tools

* Image Usage & Resolution